{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:32:44Z","timestamp":1790069564353,"version":"4.0.1"},"reference-count":62,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>As regulatory T cell (Treg) adoptive therapy continues to develop clinically, there is a need to determine which immunomodulatory agents pair most compatibly with Tregs to enable persistence and stabilize suppressor function. Prior work has shown that mechanistic target of rapamycin inhibition can increase the stability of thymic Tregs. In this study, we investigated the transcriptomic signatures of ex vivo\u2013expanded Tregs after adoptive transfer in the setting of clinically relevant immunosuppression using a nonhuman primate (NHP) model as a prelude to future transplant studies. Here, we found that adding interleukin-2 (IL-2) to rapamycin in vivo supported a logarithmic increase in the half-life of adoptively transferred carboxyfluorescein diacetate succinimidyl ester\u2013labeled, autologous NHP Tregs, effectively doubling the number of cells in the peripheral blood Treg compartment compared with Treg infusion when rapamycin was given alone. Using single-cell transcriptomics, we found that transferred ex vivo\u2013expanded Tregs initially exhibit a gene expression signature consistent with an activated state. Moreover, those cells with the highest levels of activation also expressed genes associated with p53-mediated apoptosis. In contrast, transferred Tregs interrogated at day +20 posttransfer demonstrated a gene signature more similar to published profiles of resting Tregs. Together, these preclinical data further support combining IL-2 and rapamycin in vivo as adjunctive therapy for ex vivo\u2013expanded adoptively transferred Tregs and suggest that the activation status of ex vivo\u2013expanded Tregs is critical to their persistence.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001248","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T11:59:24Z","timestamp":1587383964000},"page":"1594-1605","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":42,"title":["IL-2 enhances ex vivo\u2013expanded regulatory T-cell persistence after adoptive transfer"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3007-9840","authenticated-orcid":false,"given":"Scott N.","family":"Furlan","sequence":"first","affiliation":[{"name":"Fred Hutchinson Cancer Research Center and Department of Pediatrics, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karnail","family":"Singh","sequence":"first","affiliation":[{"name":"Cincinnati Children\u2019s Hospital, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lopez","sequence":"first","affiliation":[{"name":"Seattle Children\u2019s Research Institute and Department of Pediatrics, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6011-0576","authenticated-orcid":false,"given":"Victor","family":"Tkachev","sequence":"first","affiliation":[{"name":"Boston Children\u2019s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Joel","family":"Hunt","sequence":"first","affiliation":[{"name":"Boston Children\u2019s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hibbard","sequence":"first","affiliation":[{"name":"Seattle Children\u2019s Research Institute and Department of Pediatrics, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Betz","sequence":"first","affiliation":[{"name":"Boston Children\u2019s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9608-9841","authenticated-orcid":false,"given":"Bruce R.","family":"Blazar","sequence":"first","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-4347","authenticated-orcid":false,"given":"Cole","family":"Trapnell","sequence":"first","affiliation":[{"name":"Department of Genome Sciences, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-3926","authenticated-orcid":false,"given":"Leslie S.","family":"Kean","sequence":"first","affiliation":[{"name":"Boston Children\u2019s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"issue":"1","key":"2020042011382395500_B1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2020042011382395500_B2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2020042011382395500_B3","doi-asserted-by":"crossref","first-page":"a015552","DOI":"10.1101\/cshperspect.a015552","article-title":"Regulatory T-cell therapy in transplantation: moving to the clinic","volume":"3","author":"Tang","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"2020042011382395500_B4","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/eji.200940030","article-title":"Regulatory T cells for the prevention of graft-versus-host disease: professionals defeat amateurs","volume":"39","author":"Edinger","year":"2009","journal-title":"Eur J Immunol"},{"issue":"5","key":"2020042011382395500_B5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1189\/jlb.0407227","article-title":"Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts","volume":"82","author":"Giorgini","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2020042011382395500_B6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2006-05-025460","article-title":"In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance","volume":"109","author":"Golshayan","year":"2007","journal-title":"Blood"},{"issue":"12","key":"2020042011382395500_B7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/TP.0b013e3181ff8772","article-title":"Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model","volume":"90","author":"Issa","year":"2010","journal-title":"Transplantation"},{"issue":"11","key":"2020042011382395500_B8","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1182\/blood-2004-01-0005","article-title":"Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes","volume":"103","author":"Joffre","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2020042011382395500_B9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"issue":"2","key":"2020042011382395500_B10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.smim.2006.01.005","article-title":"CD4+CD25+ regulatory T lymphocytes in bone marrow transplantation","volume":"18","author":"Joffre","year":"2006","journal-title":"Semin Immunol"},{"issue":"2","key":"2020042011382395500_B11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4049\/jimmunol.0900936","article-title":"Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients","volume":"184","author":"Raimondi","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"2020042011382395500_B12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.exphem.2006.02.017","article-title":"Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin","volume":"34","author":"Steiner","year":"2006","journal-title":"Exp Hematol"},{"issue":"12","key":"2020042011382395500_B13","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2004-05-1850","article-title":"L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection","volume":"104","author":"Taylor","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2020042011382395500_B14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2020042011382395500_B15","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1111\/ajt.12934","article-title":"Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer","volume":"14","author":"Singh","year":"2014","journal-title":"Am J Transplant"},{"issue":"6","key":"2020042011382395500_B16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1600-6143.2011.03963.x","article-title":"Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus","volume":"12","author":"Singh","year":"2012","journal-title":"Am J Transplant"},{"issue":"315","key":"2020042011382395500_B17","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"issue":"3","key":"2020042011382395500_B18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2020042011382395500_B19","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J Immunol"},{"issue":"12","key":"2020042011382395500_B20","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"issue":"37","key":"2020042011382395500_B21","doi-asserted-by":"crossref","first-page":"16246","DOI":"10.1073\/pnas.1007422107","article-title":"Enhancement of antigen-specific Treg vaccination in vivo","volume":"107","author":"Daniel","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2020042011382395500_B22","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.4049\/jimmunol.1301181","article-title":"Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo","volume":"191","author":"Zhang","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"2020042011382395500_B23","doi-asserted-by":"crossref","first-page":"e15868","DOI":"10.1371\/journal.pone.0015868","article-title":"Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells","volume":"6","author":"Golovina","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"2020042011382395500_B24","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1111\/ajt.14338","article-title":"In vitro induction of human regulatory T cells using conditions of low tryptophan plus kynurenines","volume":"17","author":"Hippen","year":"2017","journal-title":"Am J Transplant"},{"issue":"7","key":"2020042011382395500_B25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2016-05-715896","article-title":"Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner","volume":"128","author":"McDonald-Hyman","year":"2016","journal-title":"Blood"},{"issue":"22","key":"2020042011382395500_B26","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"2020042011382395500_B27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","article-title":"Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease","volume":"128","author":"Koreth","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2020042011382395500_B28","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.4049\/jimmunol.1402540","article-title":"Combination therapy using IL-2\/IL-2 monoclonal antibody complexes, rapamycin, and islet autoantigen peptides increases regulatory T cell frequency and protects against spontaneous and induced type 1 diabetes in nonobese diabetic mice","volume":"195","author":"Manirarora","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"2020042011382395500_B29","doi-asserted-by":"crossref","first-page":"8106","DOI":"10.1038\/s41598-018-26161-6","article-title":"Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2\/anti-IL-2 monoclonal antibody complexes and peptide\/MHC tetramers","volume":"8","author":"Izquierdo","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"2020042011382395500_B30","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.4049\/jimmunol.1100061","article-title":"IL-2 controls the stability of Foxp3 expression in TGF-\u03b2-induced Foxp3+ T cells in vivo","volume":"186","author":"Chen","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"2020042011382395500_B31","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1038\/cddiscovery.2017.31","article-title":"Differential cytokine withdrawal-induced death sensitivity of effector T cells derived from distinct human CD8+ memory subsets","volume":"3","author":"Larsen","year":"2017","journal-title":"Cell Death Discov"},{"issue":"3","key":"2020042011382395500_B32","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diabetes.51.3.638","article-title":"Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice","volume":"51","author":"Rabinovitch","year":"2002","journal-title":"Diabetes"},{"issue":"12","key":"2020042011382395500_B33","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1111\/ajt.12944","article-title":"Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice","volume":"14","author":"Pilon","year":"2014","journal-title":"Am J Transplant"},{"issue":"8","key":"2020042011382395500_B34","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood-2010-10-313684","article-title":"Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells","volume":"118","author":"Shin","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2020042011382395500_B35","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs \u03b2-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"issue":"5","key":"2020042011382395500_B36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3324\/haematol.2016.153072","article-title":"IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation","volume":"102","author":"Betts","year":"2017","journal-title":"Haematologica"},{"key":"2020042011382395500_B37","first-page":"2579","article-title":"Visualizing high-dimensional data using t-SNE","volume":"9","author":"van der Maaten","year":"2008","journal-title":"J Mach Learn Res"},{"issue":"6191","key":"2020042011382395500_B38","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.1242072","article-title":"Machine learning. Clustering by fast search and find of density peaks","volume":"344","author":"Rodriguez","year":"2014","journal-title":"Science"},{"issue":"4","key":"2020042011382395500_B39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri3173","article-title":"The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation","volume":"12","author":"Weng","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2020042011382395500_B40","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"issue":"5","key":"2020042011382395500_B41","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.immuni.2018.04.008","article-title":"Proteomic analyses of human regulatory T cells reveal adaptations in signaling pathways that protect cellular identity","volume":"48","author":"Cuadrado","year":"2018","journal-title":"Immunity"},{"issue":"43","key":"2020042011382395500_B42","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2020042011382395500_B43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"27","key":"2020042011382395500_B44","doi-asserted-by":"crossref","first-page":"eaat5861","DOI":"10.1126\/sciimmunol.aat5861","article-title":"Molecular diversification of regulatory T cells in nonlymphoid tissues","volume":"3","author":"DiSpirito","year":"2018","journal-title":"Sci Immunol"},{"issue":"3","key":"2020042011382395500_B45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41590-018-0051-0","article-title":"Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR [published correction appears in Nat Immunol. 2018;19(6):645]","volume":"19","author":"Zemmour","year":"2018","journal-title":"Nat Immunol"},{"key":"2020042011382395500_B46","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","author":"Becht","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2020042011382395500_B47","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3892\/ijo.2013.1872","article-title":"RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector","volume":"42","author":"Chen","year":"2013","journal-title":"Int J Oncol"},{"issue":"1","key":"2020042011382395500_B48","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/jcmm.13338","article-title":"LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1","volume":"22","author":"Hu","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"28","key":"2020042011382395500_B49","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"issue":"4","key":"2020042011382395500_B50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2020042011382395500_B51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest"},{"issue":"8","key":"2020042011382395500_B52","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/TP.0b013e31829fa271","article-title":"Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model","volume":"96","author":"Wu","year":"2013","journal-title":"Transplantation"},{"issue":"2","key":"2020042011382395500_B53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nri.2015.1","article-title":"Regulatory T cell memory","volume":"16","author":"Rosenblum","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"13","key":"2020042011382395500_B54","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.2741\/3217","article-title":"Higher expression of Bax in regulatory T cells increases vascular inflammation","volume":"13","author":"Xiong","year":"2008","journal-title":"Front Biosci"},{"issue":"5","key":"2020042011382395500_B55","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","article-title":"Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD","volume":"105","author":"Ermann","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2020042011382395500_B56","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/j.1600-6143.2012.04065.x","article-title":"Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo","volume":"12","author":"Hester","year":"2012","journal-title":"Am J Transplant"},{"issue":"4","key":"2020042011382395500_B57","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/gutjnl-2014-306919","article-title":"Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn\u2019s disease","volume":"65","author":"Canavan","year":"2016","journal-title":"Gut"},{"issue":"1","key":"2020042011382395500_B58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1600-6143.2003.00293.x","article-title":"CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential","volume":"4","author":"Fu","year":"2004","journal-title":"Am J Transplant"},{"issue":"1","key":"2020042011382395500_B59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20020509","article-title":"Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: increased susceptibility to autoimmune disease","volume":"199","author":"Nishibori","year":"2004","journal-title":"J Exp Med"},{"issue":"6","key":"2020042011382395500_B60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1089\/jir.2016.0040","article-title":"Increased levels of STAT1 protein in blood CD4 T cells from systemic lupus erythematosus patients are associated with perturbed homeostasis of activated CD45RA-FOXP3hi regulatory subset and follow-up disease severity","volume":"37","author":"Goropev\u0161ek","year":"2017","journal-title":"J Interferon Cytokine Res"},{"issue":"6","key":"2020042011382395500_B61","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2012.11.054","article-title":"Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome","volume":"131","author":"Uzel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2020042011382395500_B62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2009.02858.x","article-title":"IFN-gamma triggered STAT1-PKB\/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells","volume":"10","author":"Wei","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/8\/1594\/1724617\/advancesadv2019001248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/8\/1594\/1724617\/advancesadv2019001248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T12:00:51Z","timestamp":1587384051000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/8\/1594\/454416\/IL2-enhances-ex-vivoexpanded-regulatory-Tcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001248","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/805531","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]}}}